About Biodesix (BDSX)
Biodesix, Inc. operates as a biotechnology company. The Company offers non-small cell lung cancer pretreatment serum tests and laboratory testing. Biodesix provides diagnostic tools and equipment for blood and tissue analysis in the United States.
- USD0.54
- USD0.58
- USD0.51
- USD2.04
- -13.20%
- 71M
- 244.03k
- 381.76k
- 79M
- 0.45
- -57.90%
Stock News
4 hours ago
Why Rigetti Computing, Inc. (RGTI) Went Up On Friday
Yahoo
yesterday
Trump administration asks the Supreme Court to restore ‘DOGE’ access to Social Security data
MarketWatch
yesterday
Here are our biggest winners and losers from Wall Street's stellar week
CNBC
yesterday
Newark flight disruptions pile up as United Airlines blames FAA staffing, technology
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
